Glaucoma Surgery Explained: Trabeculectomy, MIGS, and What to Expect

When eye drops and laser treatments no longer keep your intraocular pressure under control, surgery becomes the next step to protect your vision. Glaucoma doesn’t always cause symptoms until damage is done-so when doctors recommend surgery, it’s not about fixing what’s broken, but stopping what’s still breaking. Two main paths exist today: traditional trabeculectomy and newer MIGS procedures. Both aim to lower pressure inside the eye, but they’re not interchangeable. Choosing the right one depends on how advanced your glaucoma is, your age, your lifestyle, and what pressure level your optic nerve can safely tolerate.

What Trabeculectomy Actually Does

Trabeculectomy isn’t new-it’s been around since the 1960s. But it’s still the most effective surgery for lowering eye pressure when you need a big drop. The goal? Create a new drain. Surgeons make a small flap in the white part of your eye (the sclera), remove a tiny piece of the eye’s natural drainage tissue (the trabecular meshwork), and let fluid escape under the conjunctiva. That fluid forms a small blister-like pocket called a bleb, which slowly absorbs the fluid into your bloodstream.

This isn’t a quick fix. The surgery takes about an hour. You’ll need to avoid bending, lifting, or straining for weeks. Post-op visits are frequent-sometimes weekly for months-because the bleb can scar over, close up, or leak. About 10-15% of patients experience a bleb leak. Around 10-20% of blebs fail completely within five years. There’s also a small but serious risk: endophthalmitis (infection inside the eye), which happens in 0.5-2% of cases long-term.

But here’s the trade-off: it works. In 85-90% of cases, trabeculectomy brings eye pressure down to 5-15 mmHg. That’s a 40-60% reduction. For someone with advanced glaucoma needing pressure below 15 mmHg, this is often the only option that delivers enough control. Mass Eye and Ear’s 2023 data shows it’s still the go-to for patients with severe disease or those who’ve already tried MIGS and failed.

What MIGS Really Means for Your Eyes

MIGS stands for Minimally Invasive Glaucoma Surgery. It’s not one procedure-it’s a whole family of them, all designed to be safer, faster, and less disruptive than trabeculectomy. The first FDA-approved MIGS device, the iStent, came out in 2012. Since then, dozens more have followed: Hydrus Microstent, Xen Gel Stent, iStent infinite, GATT, and others.

These devices work in different ways. Some bypass the blocked drainage system with tiny tubes (stents). Others open up the natural drainage channels without removing tissue. Most are done at the same time as cataract surgery, using the same small incision. No big flap. No bleb. No long recovery.

The upside? Recovery is fast. Most people see clearly within a week. You can return to normal activities quickly. Complication rates are under 5%, compared to 5-15% for trabeculectomy. There’s almost no risk of infection or vision loss. And you’ll likely need fewer eye drops-on average, 1.5 to 2 fewer per day.

But there’s a catch: MIGS doesn’t lower pressure as much. Most reduce IOP by 20-30%, bringing it down to 15-18 mmHg. That’s great if your target pressure is 16 mmHg. Not enough if you need 12 mmHg. A 2025 Glaucoma Today analysis found that standalone MIGS procedures (not done with cataract surgery) still achieve solid results, but outcomes vary by device. GATT lowers pressure by 30-35%. iStent infinite by 25-30%. Xen Gel Stent? Around 25-30% too, but it’s a bit more expensive.

Cost and Accessibility: What You’ll Pay

Costs vary by region, hospital, and insurance. But here’s a general picture based on 2025 data:

• Trabeculectomy: $4,200 per eye
• Xen Gel Stent (MIGS): $6,300 per eye
• Tube shunt surgery: $5,000-$7,500 per eye

At first glance, MIGS seems pricier. But remember: MIGS often happens during cataract surgery, so you’re not paying for two separate procedures. Trabeculectomy requires months of follow-up visits, possible bleb needling (a procedure to reopen a scarred drain), and sometimes additional surgeries if it fails. MIGS patients typically need only 1-2 months of monitoring.

Insurance usually covers both, but prior authorization is often needed for MIGS, especially if it’s not done with cataract surgery. Some newer MIGS devices still face coverage delays because insurers are slow to update their policies.

Who Gets Which Surgery?

There’s no one-size-fits-all anymore. The treatment path has changed. Here’s how doctors decide now:

• Early-stage glaucoma: Start with Selective Laser Trabeculoplasty (SLT). It’s quick, safe, and costs less than eye drops over time. The 2023 LiGHT trial showed SLT works just as well as daily eye drops for controlling pressure over three years.
• Mild to moderate glaucoma: MIGS is now the standard next step. Especially if you’re already having cataract surgery. MIGS is ideal if your target pressure is 15-18 mmHg and you want to avoid lifelong drops.
• Advanced glaucoma: Trabeculectomy or tube shunt. If your optic nerve is already damaged and you need pressure below 15 mmHg, MIGS won’t cut it. Trabeculectomy remains the most reliable way to hit those low targets.
• Failed MIGS or SLT: Trabeculectomy is still the fallback. Many surgeons now use it as a second-line option after MIGS fails, not as a first.

A 2025 study from NYU Langone Health found that 65% of all standalone glaucoma surgeries in the U.S. are now MIGS. That number is climbing. But trabeculectomy hasn’t disappeared-it’s just moved down the line. For younger patients with decades of life ahead, or those with aggressive disease, it’s still the best shot at long-term pressure control.

What Recovery Looks Like

Recovery isn’t just about healing-it’s about adapting.

After trabeculectomy, you’ll wear an eye shield for a week. You’ll avoid swimming, heavy lifting, and even bending over for weeks. You’ll have frequent check-ups for 3-6 months. If your bleb starts to scar, your doctor might do a bleb needling-a quick office procedure to break up scar tissue. It’s not painful, but it’s uncomfortable. About 1 in 5 patients need this at least once.

After MIGS, you’ll probably notice better vision within days. No shield needed. You can read, watch TV, and walk the next day. Most people resume normal life in 1-2 weeks. There’s no bleb to monitor, no risk of sudden pressure drops, and almost no restrictions.

The trade-off? MIGS doesn’t give you the same level of pressure control. But for many, that’s fine. If your pressure drops from 24 to 17 mmHg and you stop taking three eye drops a day, that’s a win.

The Future: What’s Coming Next

The glaucoma surgery field is evolving fast. Newer versions of SLT, like Direct Selective Laser Trabeculoplasty (DSLT), can treat the entire drainage angle in seconds without touching the eye. It’s less precise than traditional SLT, but faster and easier for the surgeon.

Suprachoroidal shunts-tiny devices placed between layers of the eye wall-are showing promise as standalone options. They’re still experimental, but early data suggest they could offer better pressure control than MIGS without the risks of trabeculectomy.

Long-term data on MIGS is still limited. We don’t yet know how well these devices work after 10 or 15 years. But the trend is clear: doctors are moving earlier. Laser and MIGS aren’t last resorts anymore-they’re part of the first line.

What You Should Ask Your Doctor

If surgery is on the table, here’s what to ask:

• What’s my target pressure, and why?
• What’s my current pressure, and how much do I need to drop?
• Am I a candidate for SLT or MIGS first, or do I need trabeculectomy?
• What are the risks specific to my age and eye health?
• How many of these procedures have you done?
• What’s the follow-up plan? How often will I need to come in?
• Will I still need eye drops after surgery? How many?

There’s no perfect surgery. But there’s a right one for you-based on your disease, your goals, and your life.